Old Web
English
Sign In
Acemap
>
authorDetail
>
Jessica Minkue
Jessica Minkue
Ablynx
Caplacizumab
Medicine
Immunology
Adverse effect
Internal medicine
3
Papers
13
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Integrated Efficacy Results from the Phase II and Phase III Studies with Caplacizumab in Patients with Acquired Thrombotic Thrombocytopenic Purpura
2018
Blood
Flora Peyvandi
Spero R. Cataland
Marie Scully
Paul Coppo
P. Knöbl
Johanna A. Kremer Hovinga
Ara Metjian
Javier de la Rubia
Katerina Pavenski
Jessica Minkue
Filip Callewaert
Hilde De Winter
Show All
Source
Cite
Save
Citations (5)
Safety of Caplacizumab for the Treatment of Patients with Acquired Thrombotic Thrombocytopenic Purpura - Results Normalized to Time of Exposure in a Double-Blind, Placebo-Controlled, Phase 3 Hercules Study
2018
Blood
Johanna A. Kremer Hovinga
Marie Scully
Spero R. Cataland
Flora Peyvandi
Paul Coppo
Paul Knöbl
Javier de la Rubia
Katerina Pavenski
Jessica Minkue
Rui de Passos Sousa
Filip Callewaert
Hilde De Winter
Ara Metjian
Show All
Source
Cite
Save
Citations (4)
Risk Factors and Manageability of the Mainly Mild Mucocutaneous Bleeding Profile Observed in Attp Patients Treated with Caplacizumab during the Phase III Hercules Study
2018
Blood
Spero R. Cataland
Marie Scully
Flora Peyvandi
Paul Coppo
Paul Knöbl
Johanna A. Kremer Hovinga
Ara Metjian
Javier de la Rubia
Katerina Pavenski
Jessica Minkue
Rui de Passos Sousa
Filip Callewaert
Hilde De Winter
Show All
Source
Cite
Save
Citations (4)
1